MICRONAUT-S Anaerobes MIC
MICRONAUT-S Anaerobes MIC
Based on the broth microdilution (BMD) procedure, the AST plate MICRONAUT-S Anaerobes MIC provides the tool for phenotypic detection of clinically relevant resistance mechanisms in anaerobic pathogens such as Clostridium spp., Bacteroides spp. and Peptostreptococcus spp.
The increasing microbial resistance observed for anaerobic bacteria requires a standardized routine antimicrobial susceptibility test (AST) of anaerobes in the microbiological lab.
The MICRONAUT-S Anaerobes MIC is used for effective determination of antimicrobial agents which are highly active against anaerobes, inclusive compounds such as tigecycline, moxifloxacin, or ertapenem.
It includes novel antibiotics like moxifloxacin, tigecycline and ertapenem, showing good antimicrobial efficacy against anaerobic bacteria.
It is the leading tool used in microdilution methods for antibiotic susceptibility testing of anaerobes and provides consistent results with gradient methodology, with both fast and slow-growing species.
The MICRONAUT-S Anaerobes MIC is designed to offer accurate methods for MICs evaluation without the technical, interpretation and reproducibility issues which can cause delays to a labs implementation of this research.
Features and benefits
- Standardized MIC determination of antibiotics with the newly composed MICRONAUT Wilkins-Chalgren culture broth in routine laboratory diagnostics
- Due to the spectrum of antibiotics, the MIC plate is appropriate for testing anaerobic bacteria originating from hospital and community-acquired infections
- Reading and evaluation of the AST results can be performed visually or photometrically
- The MICRONAUT software provides reading, evaluation and interpretation according to the latest EUCAST or CLSI criteria
Please contact your local representative for availability in your country.
Not for sale in the USA.
More information
As of January 2022, the Legal Manufacturer of all MICRONAUT products is Bruker Daltonics GmbH & Co. KG.
